Technical Analysis for VXRT - Vaxart, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 8.14 | -1.93% | -0.16 |
VXRT closed down 1.93 percent on Friday, July 23, 2021, on 47 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Aug 4
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Historical VXRT trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | -1.93% | |
| Stochastic Reached Overbought | Strength | -1.93% | |
| Wide Bands | Range Expansion | -1.93% | |
| Overbought Stochastic | Strength | -1.93% | |
| Up 3 Days in a Row | Strength | -1.93% | |
| Up 4 Days in a Row | Strength | -1.93% | |
| Up 5 Days in a Row | Strength | -1.93% | |
| MACD Bullish Centerline Cross | Bullish | -1.69% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 3 days ago |
| Down 5% | 3 days ago |
| Down 3% | 3 days ago |
| Fell Below Previous Day's Low | 3 days ago |
| Down 2 % | 3 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/04/2021
Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Influenza Coronavirus Vaccine Vaccination Hepatitis B Papillomavirus HPV Seasonal Influenza Human Papilloma Virus Human Papillomavirus Infection
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Influenza Coronavirus Vaccine Vaccination Hepatitis B Papillomavirus HPV Seasonal Influenza Human Papilloma Virus Human Papillomavirus Infection
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 24.9 |
| 52 Week Low | 3.5 |
| Average Volume | 9,354,762 |
| 200-Day Moving Average | 7.04 |
| 50-Day Moving Average | 7.39 |
| 20-Day Moving Average | 7.62 |
| 10-Day Moving Average | 7.51 |
| Average True Range | 0.65 |
| ADX | 27.76 |
| +DI | 28.60 |
| -DI | 13.72 |
| Chandelier Exit (Long, 3 ATRs) | 6.85 |
| Chandelier Exit (Short, 3 ATRs) | 8.52 |
| Upper Bollinger Bands | 8.80 |
| Lower Bollinger Band | 6.43 |
| Percent B (%b) | 0.72 |
| BandWidth | 31.19 |
| MACD Line | 0.13 |
| MACD Signal Line | 0.02 |
| MACD Histogram | 0.1062 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.78 | ||||
| Resistance 3 (R3) | 8.76 | 8.53 | 8.67 | ||
| Resistance 2 (R2) | 8.53 | 8.37 | 8.54 | 8.64 | |
| Resistance 1 (R1) | 8.34 | 8.27 | 8.22 | 8.35 | 8.60 |
| Pivot Point | 8.11 | 8.11 | 8.05 | 8.12 | 8.11 |
| Support 1 (S1) | 7.91 | 7.95 | 7.80 | 7.93 | 7.68 |
| Support 2 (S2) | 7.68 | 7.85 | 7.69 | 7.64 | |
| Support 3 (S3) | 7.49 | 7.68 | 7.61 | ||
| Support 4 (S4) | 7.50 |
